Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04EZN
|
||||
Former ID |
DNC003326
|
||||
Drug Name |
Dimethylthiambutene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H17NS2
|
||||
Canonical SMILES |
CC(C=C(C1=CC=CS1)C2=CC=CS2)N(C)C
|
||||
InChI |
1S/C14H17NS2/c1-11(15(2)3)10-12(13-6-4-8-16-13)14-7-5-9-17-14/h4-11H,1-3H3
|
||||
InChIKey |
CANBGVXYBPOLRR-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 524-84-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Agonist | [551393] | |
Mu-type opioid receptor | Target Info | Agonist | [551393] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.